Your search matched 4 results
With lives dependent upon their decisions, oncologists are left to make treatment decisions for the betterment of their patients all while navigating a growingly crowded and complex landscape.
Oncologists want to see themselves as enabling both patient and drug success.
Suzanne Goss, Executive Vice President of Brand Strategy at Syneos Health Communications, shares her takeaways from the 2022 ASCO convention, and sheds light on the questions we need to ask ourselves as we move toward more equitable care.
Financial toxicity decreases cancer patients’ quality of life – but early identification and strategic planning can mitigate the impact overall.